You are here

  • Home
  • Archive
  • Volume 14, Issue 4
  • The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers – a study of the National Cancer Institute of Canada Clinical Trials Group

Article metrics

Article menu
Download PDFPDF
ORIGINAL ARTICLES
The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers – a study of the National Cancer Institute of Canada Clinical Trials Group

 

Online download statistics by month:

Online download statistics by month: March 2019 to September 2024

AbstractFullPdf
Mar 20191601
Apr 2019800
May 20192601
Jun 20191500
Jul 20191200
Aug 20191200
Sep 20191000
Oct 2019601
Nov 20191402
Dec 20193101
Jan 20202604
Feb 20201801
Mar 20201200
Apr 2020200
May 20201701
Jun 20201000
Jul 20201800
Aug 20201200
Sep 20205201
Oct 20204401
Nov 20203002
Dec 20202500
Jan 20213200
Feb 20211700
Mar 20212101
Apr 20211300
May 2021801
Jun 2021200
Jul 2021200
Aug 2021200
Sep 2021200
Oct 20212401
Nov 20213403
Dec 20212906
Jan 20221902
Feb 20224403
Mar 202265010
Apr 20223007
May 202283014
Jun 202274013
Jul 202256012
Aug 2022108026
Sep 2022103022
Oct 202295023
Nov 2022104013
Dec 202286025
Jan 202383035
Feb 2023216045
Mar 202388034
Apr 202397039
May 2023132044
Jun 2023164056
Jul 2023120039
Aug 2023121034
Sep 202396028
Oct 2023102032
Nov 2023143042
Dec 202399025
Jan 20242200
Feb 202459011
Mar 2024162038
Apr 2024100029
May 2024138027
Jun 202478017
Jul 2024111035
Aug 202483027
Sep 2024102024
Total37850859